This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: while using for maggot debridement therapy. OBJECTIVES: (SF9) insect cells using the baculovirus expression system (Bac-to-Bac). MATERIALS AND METHODS: collagenase into the pFastBacHTA as donor plasmid. After transposition in the bacmid of DH10Bac host, the bacmid was transfected into the Sf9 cell line, then the expressed recombinant collagenase (MMP-1) was purified using the Ni-NTA agarose. RESULTS: collagenesa enzyme. CONCLUSION: ). The result help for preparing and designing a safe and versatile recombinant drug in future.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alipour et al. (2019) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: